SlideShare a Scribd company logo
CARDIOVASCULAR
SYSTEM
Sumaira riaz
CORONARY ARTERY DISEASE
 Coronary artery disease is a progressive disease
leading to narrowing or occlusion of the coronary
arteries.
 As the vessel narrows, the patients may experience
symptoms of ischemia such as chest tightness and
angina.
PATHOPHYSIOLOGY
 Accumulation of fatty deposits and minerals in the coronary
arteries, called an atheroma or plaque, leads to stenosis and
eventually occlusion of the artery.
 In CAD, blood flow to the myocardium is reduced. The arteries are
unable to dilate to meet increased metabolic needs.
PATHOPHYSIOLOGY
 When myocardial oxygen demands are not met, ischemia results,
which can cause chest pain. The pain associated with CAD occurs
from a lack of oxygen to the myocardium from CAD and is called
angina pectoris.
 If coronary artery disease is not prevented or treated early, it can
progress to more serious cardiac disorders. These include angina,
myocardial infarction, heart failure, cardiac dysrhythmias, and
even sudden death.
S/S
 Asymptomatic.
 Chest pain (angina) because of decreased blood flow
to heart muscle and/or increase in myocardial oxygen
demand resulting from stress.
 Pain may radiate to the arms, back, and jaw.
MANAGEMENT
 Most risk factors for heart disease are related to lifestyle and
environmental factors.
 Encourage and educate the patient on cessation of smoking, dietary
changes, controlling hypertension, maintaining weight.
 Diet change: lower sodium, lower cholesterol and fat, decreased
calorie intake, increased dietary fiber
MANAGEMENT
 Administer low doses of aspirin.
 Administer beta-adrenergic blockers to reduce workload of heart:
metroprolol, propranolol, nadolol.
 Administer calcium channel blockers to reduce heart rate, blood
pressure, and muscle contractility; helps with coronary
vasodilation; slows AV node conduction.
 Administer nitrate if patient has symptomatic chest pains to reduce
discomfort and enhance blood flow to myocardium.
SURGICAL INTERVENTION
Coronary Atherectomy
 Coronary atherectomy is used to cut and remove plaque from
atherosclerotic coronary arteries. The catheter has a central
rotating blade that shaves off the plaque and contains it for removal
and pathological analysis.
Coronary Artery Stents
 Coronary artery stents are used to prevent closure of a coronary
artery from an atherosclerotic lesion. Stents are put in place during
an angioplasty.
NURSING MGT
 Monitor vital signs—signs of hypertension, irregular heart rate
 Monitor electrocardiogram
 Monitor labs—periodic lipid panel, liver function for patients on
statins
 Monitor for myalgias (muscle aches)
NURSING MGT
 Educate and encourage patients to
 Stop smoking
 Reduce alcohol consumption
 Change to a lower-fat, lower-cholesterol diet, as well as increased
dietary fiber intake
 Increase daily activity
 Weight reduction
ANGINA PECTORIS
 Angina pectoris is a clinical syndrome usually characterized by
episodes or paroxysms of pain or pressure in the anterior chest.
 The cause is usually insufficient coronary blood flow. The
insufficient flow results in a decreased oxygen supply to meet an
increased myocardial demand for oxygen in response to physical
exertion or emotional stress.
PATHOPHYSIOLOGY
 Angina pectoris (chest pain) is a symptom of ischemia and is the
primary symptom of coronary artery disease and heart attack.
 In the normal heart there is a balance between the oxygen supply
and demand of the myocardium.
 When an increased workload is placed on the heart, as in exercise or
strenuous activity, there is an increased demand for oxygen.
PATHOPHYSIOLOGY
 Normally, when the heart needs more oxygen, the coronary
arteries dilate to carry more blood.
 However, with CAD, the narrowed vessels are unable to dilate and
supply the heart with this extra blood and oxygen.
 This inability to supply more blood and oxygen causes
myocardial ischemia and chest pain. Chest pain results from the
ischemia but usually lasts only for a few minutes, especially if activity
is stopped.
 An episode of angina is typically precipitated by physical activity,
excitement, or emotional stress.
ANGINA PECTORIS
 There are three categories of angina.
Stable angina— Chest pain occurring during periods of
increased myocardial work because of reduced
coronary perfusion. The pain is predictable and can
usually be managed with nitroglycerin and rest.
ANGINA PECTORIS
 Unstable angina— The episodes of chest pain with unstable angina
increase in frequency and severity, placing the patient at risk for
myocardial damage or sudden death.
Rest does not decrease the chest pain of unstable angina. This pain
may even occur when the patient is at rest. ; is of increasing intensity,
force, or duration; isn't relieved by rest; and is slow to subside in
response to nitroglycerin.
ANGINA PECTORIS
 VARIANT ANGINA (PRINZMETAL’S ANGINA). The pain of variant
angina is similar to the pain in stable angina except it has a longer
duration and may occur at rest. The pattern of occurrence is often
cyclical, with the pain presenting about the same time each day. This
type of angina is often caused by coronary artery spasms and usually
does not cause damage to the myocardium
S/S
 Chest pain lasting 3 to 5 minutes—not all patients get substernal
pain (NB: Some pt. describe the pain as heaviness, tightness,
squeezing, or crushing pain in the center of the chest)
 Pain can occur at rest or after exertion, excitement, or exposure to
cold—due to increased oxygen demands or vasospasm.
 Pain may radiate to other parts of the body such as the jaw, back, or
arms—
S/S
 Sweating (diaphoresis)
 Tachycardia—heart pumping faster trying to meet oxygen needs as
anxiety increases.
 Difficulty breathing, shortness of breath (dyspnea)—increased
heart rate increases respiratory rate and increases oxygenation.
DIAGNOSIS
 Electrocardiogram during episode: T-wave inverted with initial
ischemia, which is reduced blood flow due to myocardium.
 Troponins, CK-MB, which is an enzyme released by damaged cardiac
tissue 2 to 6 hours following an infraction.
 Chest x-ray to determine signs of heart failure.
DIAGNOSIS
 Coronary arteriography to determine plaque build-
up in coronary arteries.
 Echocardiogram or stress-echo to determine any
abnormality of wall motion due to ischemia.
MANAGEMENT
 The treatment is directed at relieving and preventing anginal
episodes that could lead to a myocardial infarction. When
suspecting chest pain, always give oxygen as the first line of
defense.
 The risk factors identified for the patient determine the course of
treatment. Weight reduction; a low-fat, low cholesterol diet; and
stress reduction may help slow disease progression.
 The three major groups of medication used for angina are
vasodilators, calcium channel blockers, and beta blockers.
MANAGEMENT
 Administer nitrates— Nitrates dilate coronary arteries to
increase oxygen to the myocardium, and dilate peripheral vessels
so the heart does not have to work so hard to pump blood into
them.
Nitroglycerin—sublingual tablets or spray; timed-release tablets.
 Administer Calcium channel blockers: It relaxes vascular smooth
muscle, which leads to decreased peripheral vascular resistance
(afterload) and decreased myocardial oxygen demand. These drugs
dilate main coronary arteries, increasing the myocardial oxygen
supply. Nifedipine
MANAGEMENT
 Administer beta-adrenergic blocker—this class has a
cardioprotective effect, Beta blockers decrease heart rate, lower
blood pressure, and prevent release of rennin. This results in
decreased workload on the heart to help prevent anginal attacks
 Statins: Cholesterol and inflammation in artery walls are involved in
atherosclerosis development. Statins lower cholesterol levels by
reducing cholesterol production in the liver.
MANAGEMENT
 Aspirin for antiplatelet effect.
 Analgesic—typically morphine intravenously during
acute pain. The medicine is very fast-acting when
given this way and will decrease myocardial oxygen
demand as well as decrease pain.
NURSING MANAGEMENT
 Monitor vital signs—look for change in BP, P, R;
irregular pulse; pulse deficit;
 Monitor cardiac status using a 12-lead
electrocardiogram (EKG)
 Record fluid intake and output. Assess for renal
function.
 Assess chest pain each time the patient reports it.
NURSING MANAGEMENT
Remember PQRST (an acronym for a method of pain assessment)
Determine the
 Place,
 Quality (describe the pain—stabbing, squeezing, etc.),
 Radiation (does the pain travel anywhere else?),
 Severity (on a scale of 1 to 10),
 Timing (when it started and how long it lasts and what preceded the
pain).
NURSING MANAGEMENT
Educate and encourage the patient to
 Rest when pain begins to decrease oxygen demands.
 Avoid stress and activities that bring on an angina attack.
 Stop smoking. Smoking is associated with heart disease.
 Adhere to the prescribed diet and exercise plan.
MYOCARDIAL INFARCTION (MI)
 A myocardial infarction (MI), commonly known as a
heart attack, results in the death of heart muscle.
The affected myocardial cells in the heart are
permanently destroyed.
PATHO
 Myocardial infarction does not happen immediately.
Ischemic injury evolves over several hours before
complete necrosis and infarction take place.
 Blood supply to the myocardium is interrupted for
a prolonged time due to the blockage of coronary
arteries.
 The ability of the heart to contract, relax, and propel
blood throughout the body requires healthy cardiac
muscle
PATHO
 This results in insufficient oxygen reaching cardiac muscle,
causing cardiac muscles to die (necrosis).
 The body’s attempt to compensate for decreased cardiac
function triggers the sympathetic nervous system to increase heart
rate. The change in heart rate increases myocardial oxygen
demand, further depressing the myocardium.
PATHO
 The extent of the cardiac damage varies depending on the location
and amount of blockage in the coronary artery.
 Patients are typically (not always) symptomatic, but some patients
will not be aware of the event; they are said to have silent MI.
S/S
 Chest pain that is unrelieved by rest or nitroglycerin, unlike angina
 Pain that radiates to arms, jaw, back and/or neck
 Shortness of breath, especially in the elderly or women
 Nausea or vomiting
 Anxiety
S/S
 Restlessness
 Feeling of impending doom
 Pale, cool, clammy skin; sweating (diaphoresis)
 Sudden death due to arrhythmia usually occurs within first hour
DIAGNOSIS
 ECG: T-wave inversion—sign of ischemia.
ST-segment elevation
 Decreased pulse pressure because of diminished cardiac output.
 Elevated creatine kinase MB (CK-MB)—
 Elevated troponin I- and troponin T-proteins elevated within one
hour of myocardial damage.
 Less than 25 ml/hr of urine output due to lack of renal blood flow
MANAGEMENT
 The goal of medical management is to minimize myocardial
damage, preserve myocardial function, and prevent
complications.
 Medications are used to enhance blood flow to the heart muscle
while reducing the workload of the heart.
 OXYGEN: Supplemental oxygen is used to help meet myocardial
oxygen demand. Oxygen is administered immediately, usually at 2 L
per minute via nasal cannula.
MANAGEMENT
 Administer antiarrhythmics because arrhythmias are common as
are conduction disturbances.
Amiodarone.
 Administer thrombolytic therapy within 3 to 12 hours of onset
because it can re-establish blood flow in an occluded artery, reduce
mortality, and halt the size of the infarction.
Alteplase. Streptokinase.
 Administer beta-adrenergic blockers because they reduce the
duration of ischemic pain and the incidence of ventricular
fibrillation; decreases mortality.
Propranolol, Nadolol.
MANAGEMENT
 Administer analgesics to relieve pain, reduce pulmonary
congestion, and decrease myocardial oxygen consumption.
Morphine sulfate is the most commonly used narcotic for
several reasons
 Administer nitrates to reduce ischemic pain by dilation of blood
vessels; helps to lower BP. Nitroglycerin.
 Post-MI all patients should be commenced on a statin lipid
lowering drug.
NURSING MANAGEMENT
 Monitor Vital signs, look out for changes in pulse, heart sounds,
murmur.
 Continuous monitoring of ECG to detect arrhythmias
 Educate and encourage the patient on
low-fat, low-cholesterol, low-sodium diet.
Medication.
Smoking cessation.
NURSING MANAGEMENT
Patient should be encouraged to
 Limit activities.
 Reduce stress
 Adhere to lifestyle changes such as increase in exercise, diet changes.
HEART FAILURE
 Is a complication of other cardiovascular condition
rather than a disease in itself.
 HF occurs when the muscular layer of the heart
weakens causing it to fail as a pump and a circulator
of blood.
CAUSES
 Infection of the muscle
 Myocardial infraction
 Ageing
 Long standing HTN
PATHO
 Heart failure is a complex syndrome that can result from any cardiac
disorder (structural or functional) resulting in a failure to maintain
sufficient cardiac output to meet the demands of the body.
 The clinical syndrome of heart failure is characterised by
breathlessness, fatigue and fluid retention.
PATHO
 The mechanism by which the heart fails to deliver a sufficient cardiac
output is dependent on the underlying cause. The circulatory
system is exactly that: a system failure of one component affects
the entire system.
 HF may be classified as right sided HF or left sided HF.
LEFT SIDED HF
 It can be caused by Aortic Stenosis, Cardiomyopathy, Hypertension,
Heart Muscle Infections, Myocardial Infarction etc
 Normally, the ventricles of the heart contracts while the atria relax allowing
for filling and emptying.
 If the muscle of the left ventricle cannot contract effectively, some blood
is left in the left ventricle.
LEFT SIDED HF
 This prevent part of the blood in the left atrium from progressing
into the ventricle and in turn blood backs up into the pulmonary
vessel, pressure within those vessels increases and fluid leaks into
lung tissue producing congestion
 Alveolar edema is more serious because it reduces gas exchange
across the alveolar capillary membrane. Shortness of breath and
cyanosis may result from the decreased oxygenation of the blood
leaving the lungs and eventually pulmonary oedema.
 If not corrected, left sided heart failure will lead to failure of the
right side of the heart.
S/S LEFT-SIDED HEART FAILURE
 Dyspnea on exertion
 Dry hacky cough, especially supine
 Crackles, wheezing
 Orthopnea
 Paroxysmal nocturnal dyspnea
 Cyanosis
 Tachypnea, tachycardia
 Nocturia.
RIGHT SIDED HF
 It can be caused by chronic lung disease (cor pulmonale),
pulmonary embolism, pulmonary hypertension, Left-Sided Heart
Failure etc
 The major cause of right-sided heart failure is leftsided heart failure.
When the left side fails, fluid backs up into the lungs and
pulmonary pressure is increased. The right ventricle must
continually pump blood against this RESISTANCE.
 Right sided HF leads to backward build-up of blood in the
systemic blood vessels. As the blood backs up jugular neck veins
become distended
RIGHT SIDED HF
 Edema may occur in the peripheral tissues, and the abdominal
organs can become engorged.
 Congestion in the gastrointestinal tract causes anorexia, nausea, and
abdominal pain. The liver can becomes congested, known as
hepatomegaly.
 Congestion of the blood to and from the kidney may lead to
impaired renal function, preventing normal excretion of urine and
causing fluid accumulation.
 Inadequate circulation to and from the brain may cause mental
confusion and irritability which sometimes progresses to delirium
and coma.
S/S RIGHT-SIDED HEART FAILURE Jugular vein distention
 Dependent peripheral edema
 Ascites
 Weight gain
 GI pain, anorexia, nausea
 Fatigue, weakness
 Tachycardia
 Nocturia
DIAGNOSTIC EVALUATION
 Physical examination
 Electrocardiogram
 Chest x-ray examination
 Coronary angiography
MANAGEMENT
Treatment is aimed at the underlying disease and to improve the
heart’s pumping ability and decrease the heart’s oxygen demands.
 Oxygen therapy: Oxygen therapy assists in supplying the oxygen
needs of the tissue.
 Diuretics: It is usually administer for symptom control e.g
Furosemide, hydrochlorothiazide, spironolactone
 ACE inhibitors: it is administer to decrease afterload e.g Captopril,
enalapril, lisinopril.
 Beta blockers: It help to raise ejection fraction, and decrease
ventricular size.
MANAGEMENT
 Inotrope: It strengthen myocardial contractility: Digoxin.
 Vasodilator: It is given to reduce preload, relieve dyspnea: e.g
nitroprusside,
 Anticoagulants: it is given to a patients with severe heart failure, as
they have a propensity to develop thrombus and emboli
 Reduce fluids as fluid overload is a causative factor in CHF
NURSING MGT
 Monitor vital signs
 Record fluid intake and output—weigh daily to assess
for fluid overload.
 Position patient in semi-Fowler’s position to ease
breathing
NURSING MGT
 Administer oxygen as ordered because it helps to decrease
workload of heart.
 Raise legs when sitting to lessen dependent edema.
 Patients should be advised to stop smoking and reduce alcohol
and salt intake.
 Weight loss and regular aerobic exercise should be encouraged.
 Patients with evidence of fluid overload should restrict their fluid
intake

More Related Content

What's hot

Angina pectoris-ICD-10-CM-2017
Angina pectoris-ICD-10-CM-2017Angina pectoris-ICD-10-CM-2017
Angina pectoris-ICD-10-CM-2017
Medesun Healthcare Solutions LLC
 
Pathophysiology of angina and atheroslerosis
Pathophysiology of angina and atheroslerosisPathophysiology of angina and atheroslerosis
Pathophysiology of angina and atheroslerosis
Koppala RVS Chaitanya
 
UNSTABLE ANGINA case study
UNSTABLE ANGINA  case studyUNSTABLE ANGINA  case study
UNSTABLE ANGINA case study
merugusaisruthi
 
Angina pectoris
Angina pectorisAngina pectoris
Angina With Nursing Care
Angina With Nursing CareAngina With Nursing Care
Angina With Nursing Care
Royal College of Nursing
 
Angina
AnginaAngina
Angina
fitango
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
BbconBbcon
 
ANGINA PECTORIS
ANGINA PECTORISANGINA PECTORIS
ANGINA PECTORISParth Shah
 
Disorders of myocardial blood supply
Disorders of myocardial blood supplyDisorders of myocardial blood supply
Disorders of myocardial blood supply
department nursing sci.
 
Angina seminar
Angina seminarAngina seminar
Angina seminar
urmisthasarkar
 
Angina pectoris : causes, symptoms, diagnosis and treatment
Angina pectoris : causes, symptoms, diagnosis and treatmentAngina pectoris : causes, symptoms, diagnosis and treatment
Angina pectoris : causes, symptoms, diagnosis and treatment
Lazoi Lifecare Private Limited
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
Taher Haddad
 
Cad
CadCad
Angina
AnginaAngina
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
AMMU M
 
Coronary heart diseases
Coronary heart diseases Coronary heart diseases
Coronary heart diseases
anishkumar123
 

What's hot (20)

Angina pectoris-ICD-10-CM-2017
Angina pectoris-ICD-10-CM-2017Angina pectoris-ICD-10-CM-2017
Angina pectoris-ICD-10-CM-2017
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Pathophysiology of angina and atheroslerosis
Pathophysiology of angina and atheroslerosisPathophysiology of angina and atheroslerosis
Pathophysiology of angina and atheroslerosis
 
Angina Pectoris
Angina PectorisAngina Pectoris
Angina Pectoris
 
UNSTABLE ANGINA case study
UNSTABLE ANGINA  case studyUNSTABLE ANGINA  case study
UNSTABLE ANGINA case study
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Angina With Nursing Care
Angina With Nursing CareAngina With Nursing Care
Angina With Nursing Care
 
Angina
AnginaAngina
Angina
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
ANGINA PECTORIS
ANGINA PECTORISANGINA PECTORIS
ANGINA PECTORIS
 
Disorders of myocardial blood supply
Disorders of myocardial blood supplyDisorders of myocardial blood supply
Disorders of myocardial blood supply
 
Angina seminar
Angina seminarAngina seminar
Angina seminar
 
Angina pectoris : causes, symptoms, diagnosis and treatment
Angina pectoris : causes, symptoms, diagnosis and treatmentAngina pectoris : causes, symptoms, diagnosis and treatment
Angina pectoris : causes, symptoms, diagnosis and treatment
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
angina presentation
angina presentationangina presentation
angina presentation
 
Cad
CadCad
Cad
 
Angina
AnginaAngina
Angina
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
CAD+And+ACS
CAD+And+ACSCAD+And+ACS
CAD+And+ACS
 
Coronary heart diseases
Coronary heart diseases Coronary heart diseases
Coronary heart diseases
 

Similar to 13942698

M5 - Angina
M5 - AnginaM5 - Angina
M5 - Angina
Bibul2
 
Ischemic Heart Disease.ppt
Ischemic Heart Disease.pptIschemic Heart Disease.ppt
Ischemic Heart Disease.pptShama
 
IHD- MI,Unstable Angina- Dr Sabu Augustine
IHD- MI,Unstable Angina- Dr Sabu AugustineIHD- MI,Unstable Angina- Dr Sabu Augustine
IHD- MI,Unstable Angina- Dr Sabu Augustine
drsabuaugustine
 
CHRONIC HEART DISEASE (CHD)
CHRONIC HEART DISEASE (CHD)CHRONIC HEART DISEASE (CHD)
CHRONIC HEART DISEASE (CHD)
MULLAPUDI RAMAKRISHNA
 
Angina pectoris and myocardial infraction.pptx
Angina pectoris and myocardial infraction.pptxAngina pectoris and myocardial infraction.pptx
Angina pectoris and myocardial infraction.pptx
SHIVANEE VYAS
 
Ischemic heart diseae lecture
Ischemic heart diseae lectureIschemic heart diseae lecture
Ischemic heart diseae lecture
memoalawad
 
3. coronary artery disease (cad)
3. coronary artery disease (cad)3. coronary artery disease (cad)
3. coronary artery disease (cad)
khizraarshed
 
Angina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptxAngina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptx
Muhammad Kamal Hossain
 
The heart
The heartThe heart
The heart
Amna Medani
 
Clinical pharmacy in Cardiology
Clinical pharmacy in CardiologyClinical pharmacy in Cardiology
Clinical pharmacy in Cardiology
Eneutron
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
Bahati Abdallah
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
MD Danish Rizvi
 
CAD presentation
CAD presentationCAD presentation
CAD presentation
Thieu Hy Huynh
 
Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
Kaylie Kristen
 
clinical pharmacy in cardiology
clinical pharmacy in cardiology clinical pharmacy in cardiology
clinical pharmacy in cardiology
Oyeleke Mary Oluwadunsin
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
Priya
 
Angina
Angina Angina
Angina
Amira Badr
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
sivasakthikannappan1
 

Similar to 13942698 (20)

M5 - Angina
M5 - AnginaM5 - Angina
M5 - Angina
 
Ischemic Heart Disease.ppt
Ischemic Heart Disease.pptIschemic Heart Disease.ppt
Ischemic Heart Disease.ppt
 
IHD- MI,Unstable Angina- Dr Sabu Augustine
IHD- MI,Unstable Angina- Dr Sabu AugustineIHD- MI,Unstable Angina- Dr Sabu Augustine
IHD- MI,Unstable Angina- Dr Sabu Augustine
 
CHRONIC HEART DISEASE (CHD)
CHRONIC HEART DISEASE (CHD)CHRONIC HEART DISEASE (CHD)
CHRONIC HEART DISEASE (CHD)
 
Angina pectoris and myocardial infraction.pptx
Angina pectoris and myocardial infraction.pptxAngina pectoris and myocardial infraction.pptx
Angina pectoris and myocardial infraction.pptx
 
Ischemic heart diseae lecture
Ischemic heart diseae lectureIschemic heart diseae lecture
Ischemic heart diseae lecture
 
3. coronary artery disease (cad)
3. coronary artery disease (cad)3. coronary artery disease (cad)
3. coronary artery disease (cad)
 
Angina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptxAngina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptx
 
The heart
The heartThe heart
The heart
 
Clinical pharmacy in Cardiology
Clinical pharmacy in CardiologyClinical pharmacy in Cardiology
Clinical pharmacy in Cardiology
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
IHD
IHDIHD
IHD
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
CAD presentation
CAD presentationCAD presentation
CAD presentation
 
Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
 
clinical pharmacy in cardiology
clinical pharmacy in cardiology clinical pharmacy in cardiology
clinical pharmacy in cardiology
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Angina
Angina Angina
Angina
 
Ischmic heart disease
Ischmic heart diseaseIschmic heart disease
Ischmic heart disease
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 

Recently uploaded

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

13942698

  • 2. CORONARY ARTERY DISEASE  Coronary artery disease is a progressive disease leading to narrowing or occlusion of the coronary arteries.  As the vessel narrows, the patients may experience symptoms of ischemia such as chest tightness and angina.
  • 3. PATHOPHYSIOLOGY  Accumulation of fatty deposits and minerals in the coronary arteries, called an atheroma or plaque, leads to stenosis and eventually occlusion of the artery.  In CAD, blood flow to the myocardium is reduced. The arteries are unable to dilate to meet increased metabolic needs.
  • 4. PATHOPHYSIOLOGY  When myocardial oxygen demands are not met, ischemia results, which can cause chest pain. The pain associated with CAD occurs from a lack of oxygen to the myocardium from CAD and is called angina pectoris.  If coronary artery disease is not prevented or treated early, it can progress to more serious cardiac disorders. These include angina, myocardial infarction, heart failure, cardiac dysrhythmias, and even sudden death.
  • 5. S/S  Asymptomatic.  Chest pain (angina) because of decreased blood flow to heart muscle and/or increase in myocardial oxygen demand resulting from stress.  Pain may radiate to the arms, back, and jaw.
  • 6. MANAGEMENT  Most risk factors for heart disease are related to lifestyle and environmental factors.  Encourage and educate the patient on cessation of smoking, dietary changes, controlling hypertension, maintaining weight.  Diet change: lower sodium, lower cholesterol and fat, decreased calorie intake, increased dietary fiber
  • 7. MANAGEMENT  Administer low doses of aspirin.  Administer beta-adrenergic blockers to reduce workload of heart: metroprolol, propranolol, nadolol.  Administer calcium channel blockers to reduce heart rate, blood pressure, and muscle contractility; helps with coronary vasodilation; slows AV node conduction.  Administer nitrate if patient has symptomatic chest pains to reduce discomfort and enhance blood flow to myocardium.
  • 8. SURGICAL INTERVENTION Coronary Atherectomy  Coronary atherectomy is used to cut and remove plaque from atherosclerotic coronary arteries. The catheter has a central rotating blade that shaves off the plaque and contains it for removal and pathological analysis. Coronary Artery Stents  Coronary artery stents are used to prevent closure of a coronary artery from an atherosclerotic lesion. Stents are put in place during an angioplasty.
  • 9. NURSING MGT  Monitor vital signs—signs of hypertension, irregular heart rate  Monitor electrocardiogram  Monitor labs—periodic lipid panel, liver function for patients on statins  Monitor for myalgias (muscle aches)
  • 10. NURSING MGT  Educate and encourage patients to  Stop smoking  Reduce alcohol consumption  Change to a lower-fat, lower-cholesterol diet, as well as increased dietary fiber intake  Increase daily activity  Weight reduction
  • 11. ANGINA PECTORIS  Angina pectoris is a clinical syndrome usually characterized by episodes or paroxysms of pain or pressure in the anterior chest.  The cause is usually insufficient coronary blood flow. The insufficient flow results in a decreased oxygen supply to meet an increased myocardial demand for oxygen in response to physical exertion or emotional stress.
  • 12. PATHOPHYSIOLOGY  Angina pectoris (chest pain) is a symptom of ischemia and is the primary symptom of coronary artery disease and heart attack.  In the normal heart there is a balance between the oxygen supply and demand of the myocardium.  When an increased workload is placed on the heart, as in exercise or strenuous activity, there is an increased demand for oxygen.
  • 13. PATHOPHYSIOLOGY  Normally, when the heart needs more oxygen, the coronary arteries dilate to carry more blood.  However, with CAD, the narrowed vessels are unable to dilate and supply the heart with this extra blood and oxygen.  This inability to supply more blood and oxygen causes myocardial ischemia and chest pain. Chest pain results from the ischemia but usually lasts only for a few minutes, especially if activity is stopped.  An episode of angina is typically precipitated by physical activity, excitement, or emotional stress.
  • 14. ANGINA PECTORIS  There are three categories of angina. Stable angina— Chest pain occurring during periods of increased myocardial work because of reduced coronary perfusion. The pain is predictable and can usually be managed with nitroglycerin and rest.
  • 15. ANGINA PECTORIS  Unstable angina— The episodes of chest pain with unstable angina increase in frequency and severity, placing the patient at risk for myocardial damage or sudden death. Rest does not decrease the chest pain of unstable angina. This pain may even occur when the patient is at rest. ; is of increasing intensity, force, or duration; isn't relieved by rest; and is slow to subside in response to nitroglycerin.
  • 16. ANGINA PECTORIS  VARIANT ANGINA (PRINZMETAL’S ANGINA). The pain of variant angina is similar to the pain in stable angina except it has a longer duration and may occur at rest. The pattern of occurrence is often cyclical, with the pain presenting about the same time each day. This type of angina is often caused by coronary artery spasms and usually does not cause damage to the myocardium
  • 17. S/S  Chest pain lasting 3 to 5 minutes—not all patients get substernal pain (NB: Some pt. describe the pain as heaviness, tightness, squeezing, or crushing pain in the center of the chest)  Pain can occur at rest or after exertion, excitement, or exposure to cold—due to increased oxygen demands or vasospasm.  Pain may radiate to other parts of the body such as the jaw, back, or arms—
  • 18. S/S  Sweating (diaphoresis)  Tachycardia—heart pumping faster trying to meet oxygen needs as anxiety increases.  Difficulty breathing, shortness of breath (dyspnea)—increased heart rate increases respiratory rate and increases oxygenation.
  • 19. DIAGNOSIS  Electrocardiogram during episode: T-wave inverted with initial ischemia, which is reduced blood flow due to myocardium.  Troponins, CK-MB, which is an enzyme released by damaged cardiac tissue 2 to 6 hours following an infraction.  Chest x-ray to determine signs of heart failure.
  • 20. DIAGNOSIS  Coronary arteriography to determine plaque build- up in coronary arteries.  Echocardiogram or stress-echo to determine any abnormality of wall motion due to ischemia.
  • 21. MANAGEMENT  The treatment is directed at relieving and preventing anginal episodes that could lead to a myocardial infarction. When suspecting chest pain, always give oxygen as the first line of defense.  The risk factors identified for the patient determine the course of treatment. Weight reduction; a low-fat, low cholesterol diet; and stress reduction may help slow disease progression.  The three major groups of medication used for angina are vasodilators, calcium channel blockers, and beta blockers.
  • 22. MANAGEMENT  Administer nitrates— Nitrates dilate coronary arteries to increase oxygen to the myocardium, and dilate peripheral vessels so the heart does not have to work so hard to pump blood into them. Nitroglycerin—sublingual tablets or spray; timed-release tablets.  Administer Calcium channel blockers: It relaxes vascular smooth muscle, which leads to decreased peripheral vascular resistance (afterload) and decreased myocardial oxygen demand. These drugs dilate main coronary arteries, increasing the myocardial oxygen supply. Nifedipine
  • 23. MANAGEMENT  Administer beta-adrenergic blocker—this class has a cardioprotective effect, Beta blockers decrease heart rate, lower blood pressure, and prevent release of rennin. This results in decreased workload on the heart to help prevent anginal attacks  Statins: Cholesterol and inflammation in artery walls are involved in atherosclerosis development. Statins lower cholesterol levels by reducing cholesterol production in the liver.
  • 24. MANAGEMENT  Aspirin for antiplatelet effect.  Analgesic—typically morphine intravenously during acute pain. The medicine is very fast-acting when given this way and will decrease myocardial oxygen demand as well as decrease pain.
  • 25. NURSING MANAGEMENT  Monitor vital signs—look for change in BP, P, R; irregular pulse; pulse deficit;  Monitor cardiac status using a 12-lead electrocardiogram (EKG)  Record fluid intake and output. Assess for renal function.  Assess chest pain each time the patient reports it.
  • 26. NURSING MANAGEMENT Remember PQRST (an acronym for a method of pain assessment) Determine the  Place,  Quality (describe the pain—stabbing, squeezing, etc.),  Radiation (does the pain travel anywhere else?),  Severity (on a scale of 1 to 10),  Timing (when it started and how long it lasts and what preceded the pain).
  • 27. NURSING MANAGEMENT Educate and encourage the patient to  Rest when pain begins to decrease oxygen demands.  Avoid stress and activities that bring on an angina attack.  Stop smoking. Smoking is associated with heart disease.  Adhere to the prescribed diet and exercise plan.
  • 28. MYOCARDIAL INFARCTION (MI)  A myocardial infarction (MI), commonly known as a heart attack, results in the death of heart muscle. The affected myocardial cells in the heart are permanently destroyed.
  • 29. PATHO  Myocardial infarction does not happen immediately. Ischemic injury evolves over several hours before complete necrosis and infarction take place.  Blood supply to the myocardium is interrupted for a prolonged time due to the blockage of coronary arteries.  The ability of the heart to contract, relax, and propel blood throughout the body requires healthy cardiac muscle
  • 30. PATHO  This results in insufficient oxygen reaching cardiac muscle, causing cardiac muscles to die (necrosis).  The body’s attempt to compensate for decreased cardiac function triggers the sympathetic nervous system to increase heart rate. The change in heart rate increases myocardial oxygen demand, further depressing the myocardium.
  • 31. PATHO  The extent of the cardiac damage varies depending on the location and amount of blockage in the coronary artery.  Patients are typically (not always) symptomatic, but some patients will not be aware of the event; they are said to have silent MI.
  • 32. S/S  Chest pain that is unrelieved by rest or nitroglycerin, unlike angina  Pain that radiates to arms, jaw, back and/or neck  Shortness of breath, especially in the elderly or women  Nausea or vomiting  Anxiety
  • 33. S/S  Restlessness  Feeling of impending doom  Pale, cool, clammy skin; sweating (diaphoresis)  Sudden death due to arrhythmia usually occurs within first hour
  • 34. DIAGNOSIS  ECG: T-wave inversion—sign of ischemia. ST-segment elevation  Decreased pulse pressure because of diminished cardiac output.  Elevated creatine kinase MB (CK-MB)—  Elevated troponin I- and troponin T-proteins elevated within one hour of myocardial damage.  Less than 25 ml/hr of urine output due to lack of renal blood flow
  • 35. MANAGEMENT  The goal of medical management is to minimize myocardial damage, preserve myocardial function, and prevent complications.  Medications are used to enhance blood flow to the heart muscle while reducing the workload of the heart.  OXYGEN: Supplemental oxygen is used to help meet myocardial oxygen demand. Oxygen is administered immediately, usually at 2 L per minute via nasal cannula.
  • 36. MANAGEMENT  Administer antiarrhythmics because arrhythmias are common as are conduction disturbances. Amiodarone.  Administer thrombolytic therapy within 3 to 12 hours of onset because it can re-establish blood flow in an occluded artery, reduce mortality, and halt the size of the infarction. Alteplase. Streptokinase.  Administer beta-adrenergic blockers because they reduce the duration of ischemic pain and the incidence of ventricular fibrillation; decreases mortality. Propranolol, Nadolol.
  • 37. MANAGEMENT  Administer analgesics to relieve pain, reduce pulmonary congestion, and decrease myocardial oxygen consumption. Morphine sulfate is the most commonly used narcotic for several reasons  Administer nitrates to reduce ischemic pain by dilation of blood vessels; helps to lower BP. Nitroglycerin.  Post-MI all patients should be commenced on a statin lipid lowering drug.
  • 38. NURSING MANAGEMENT  Monitor Vital signs, look out for changes in pulse, heart sounds, murmur.  Continuous monitoring of ECG to detect arrhythmias  Educate and encourage the patient on low-fat, low-cholesterol, low-sodium diet. Medication. Smoking cessation.
  • 39. NURSING MANAGEMENT Patient should be encouraged to  Limit activities.  Reduce stress  Adhere to lifestyle changes such as increase in exercise, diet changes.
  • 40. HEART FAILURE  Is a complication of other cardiovascular condition rather than a disease in itself.  HF occurs when the muscular layer of the heart weakens causing it to fail as a pump and a circulator of blood.
  • 41. CAUSES  Infection of the muscle  Myocardial infraction  Ageing  Long standing HTN
  • 42. PATHO  Heart failure is a complex syndrome that can result from any cardiac disorder (structural or functional) resulting in a failure to maintain sufficient cardiac output to meet the demands of the body.  The clinical syndrome of heart failure is characterised by breathlessness, fatigue and fluid retention.
  • 43. PATHO  The mechanism by which the heart fails to deliver a sufficient cardiac output is dependent on the underlying cause. The circulatory system is exactly that: a system failure of one component affects the entire system.  HF may be classified as right sided HF or left sided HF.
  • 44. LEFT SIDED HF  It can be caused by Aortic Stenosis, Cardiomyopathy, Hypertension, Heart Muscle Infections, Myocardial Infarction etc  Normally, the ventricles of the heart contracts while the atria relax allowing for filling and emptying.  If the muscle of the left ventricle cannot contract effectively, some blood is left in the left ventricle.
  • 45. LEFT SIDED HF  This prevent part of the blood in the left atrium from progressing into the ventricle and in turn blood backs up into the pulmonary vessel, pressure within those vessels increases and fluid leaks into lung tissue producing congestion  Alveolar edema is more serious because it reduces gas exchange across the alveolar capillary membrane. Shortness of breath and cyanosis may result from the decreased oxygenation of the blood leaving the lungs and eventually pulmonary oedema.  If not corrected, left sided heart failure will lead to failure of the right side of the heart.
  • 46. S/S LEFT-SIDED HEART FAILURE  Dyspnea on exertion  Dry hacky cough, especially supine  Crackles, wheezing  Orthopnea  Paroxysmal nocturnal dyspnea  Cyanosis  Tachypnea, tachycardia  Nocturia.
  • 47. RIGHT SIDED HF  It can be caused by chronic lung disease (cor pulmonale), pulmonary embolism, pulmonary hypertension, Left-Sided Heart Failure etc  The major cause of right-sided heart failure is leftsided heart failure. When the left side fails, fluid backs up into the lungs and pulmonary pressure is increased. The right ventricle must continually pump blood against this RESISTANCE.  Right sided HF leads to backward build-up of blood in the systemic blood vessels. As the blood backs up jugular neck veins become distended
  • 48. RIGHT SIDED HF  Edema may occur in the peripheral tissues, and the abdominal organs can become engorged.  Congestion in the gastrointestinal tract causes anorexia, nausea, and abdominal pain. The liver can becomes congested, known as hepatomegaly.  Congestion of the blood to and from the kidney may lead to impaired renal function, preventing normal excretion of urine and causing fluid accumulation.  Inadequate circulation to and from the brain may cause mental confusion and irritability which sometimes progresses to delirium and coma.
  • 49. S/S RIGHT-SIDED HEART FAILURE Jugular vein distention  Dependent peripheral edema  Ascites  Weight gain  GI pain, anorexia, nausea  Fatigue, weakness  Tachycardia  Nocturia
  • 50. DIAGNOSTIC EVALUATION  Physical examination  Electrocardiogram  Chest x-ray examination  Coronary angiography
  • 51. MANAGEMENT Treatment is aimed at the underlying disease and to improve the heart’s pumping ability and decrease the heart’s oxygen demands.  Oxygen therapy: Oxygen therapy assists in supplying the oxygen needs of the tissue.  Diuretics: It is usually administer for symptom control e.g Furosemide, hydrochlorothiazide, spironolactone  ACE inhibitors: it is administer to decrease afterload e.g Captopril, enalapril, lisinopril.  Beta blockers: It help to raise ejection fraction, and decrease ventricular size.
  • 52. MANAGEMENT  Inotrope: It strengthen myocardial contractility: Digoxin.  Vasodilator: It is given to reduce preload, relieve dyspnea: e.g nitroprusside,  Anticoagulants: it is given to a patients with severe heart failure, as they have a propensity to develop thrombus and emboli  Reduce fluids as fluid overload is a causative factor in CHF
  • 53. NURSING MGT  Monitor vital signs  Record fluid intake and output—weigh daily to assess for fluid overload.  Position patient in semi-Fowler’s position to ease breathing
  • 54. NURSING MGT  Administer oxygen as ordered because it helps to decrease workload of heart.  Raise legs when sitting to lessen dependent edema.  Patients should be advised to stop smoking and reduce alcohol and salt intake.  Weight loss and regular aerobic exercise should be encouraged.  Patients with evidence of fluid overload should restrict their fluid intake